AVITA Medical, Inc. (RCEL) Other financing activities (2020 - 2025)

AVITA Medical (RCEL) has reported Other financing activities for 6 consecutive years, with $1000.0 the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Other financing activities fell 99.77% year-over-year to $1000.0; the trailing twelve-month figure through Dec 2025 stood at $407000.0 (down 80.94% YoY), and the FY2025 full-year result was $407000.0, down 80.94% from the prior year.
• Other financing activities fell to $1000.0 in Q4 2025 per RCEL's latest filing, from $32000.0 in the prior quarter.
• Across five years, Other financing activities topped out at $1.0 million in Q3 2024 and bottomed at -$25000.0 in Q4 2021.
• Historically, Other financing activities has averaged $263000.0 across 5 years, with a median of $66000.0 in 2021.
• The sharpest annual moves came in 2023 and 2025: Other financing activities jumped 17000.0% in 2023, then tumbled 99.77% in 2025.
• Over 5 years, Other financing activities stood at -$25000.0 in 2021, then soared by 3696.0% to $899000.0 in 2022, then tumbled by 98.33% to $15000.0 in 2023, then soared by 2793.33% to $434000.0 in 2024, then sank by 99.77% to $1000.0 in 2025.
• According to Business Quant data, Other financing activities over the past three periods registered $1000.0, $32000.0, and $11000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.